By vgreene, 15 January, 2015 Postconversion maintenance drug options<sup>30</sup> based on CAD/LVH/HF, comorbidities, drug risks [I/A], +/- rate-control tx. OK to continue antiarrhythmic despite infrequent, well-tolerated, recurrences [IIb/C]; stop if AF becomes permanent [III/B]
By vgreene, 15 January, 2015 Postconversion pill-in-pocket prn option: propafenone/flecainide + BB/non-DHB-CCB (diltiazem/verapamil), once proven safe in monitored setting, reasonable to terminate out-pt AF [IIa/B]
By vgreene, 15 January, 2015 Pharmacologic cardioversion<sup>30</sup> + peri-procedural anticoagulation<sup>29</sup> + rate-control tx: flecainide, dofetilide, propafenone, IV ibutilide [I/A] or amiodarone<sup>31</sup> [IIa/A]
By vgreene, 15 January, 2015 DC cardiovert [I/B] + peri-procedural anticoagulation.<sup>29</sup> Repeat/serial attempts based on sinus rhythm duration, sx, pt preference<sup>29</sup> +/- rate-control tx [IIa/C]
By vgreene, 15 January, 2015 Anticoagulate<sup>27,28</sup> based on stroke/bleed risks, renal fxn, pt preference [I/C]
By vgreene, 15 January, 2015 If postcoronary revasc (PCI/surg): reasonable to add clopidogrel 75 mg/day (not aspirin) to anticoagulant [IIb/B]
By vgreene, 15 January, 2015 Cath ablation<sup>25</sup> + peri-ablation anticoagulation<sup>23</sup> is an option; factor risk/benefit, pt preference.